A direct study of the complement-fixing reactivity of cell membranes, soluble components of cell membranes and cell interiors of lymphoblast cell lines showed that with highly concentrated levels of antigen, complement-fixing reactivity could be measured consistently between the cell interior of lymphoma (IM1), leukaemic (4265) and Burkitt lymphoma (P3) cultured cells and sera from patients with infectious mononucleosis or Burkitt lymphoma. A measurable complement-fixing reactive cell-membrane antigen appeared to be present in IM1 and 4265 cells. Complement-fixing activity was also recovered in a soluble fraction of 4265 cell membranes after sonication and separation by Sephadex gel filtration. Separation of the complement-fixing reactive component from HL-A antigens was achieved by gel electrophoresis.
INTRODUCTION
Although turnout-related antigens can be detected as soluble or insoluble components of the cell membranes of DNA virus-induced tumours, there is no specific demonstration that there is a direct or indirect relationship of such antigens to the viruses which appear to induce them. Such antigens share much in common, both chemically and biologically, with hostdetermined membrane-located isoantigens, and it is not known whether tumour-related antigens result from altered histocompatibility antigens, enzymes, the products of genetic derepression, or activation of virus hereditary information in RNA or DNA.
Several investigators have demonstrated Epstein-Barr virus (EBV) or virus-associated antigens in most Burkitt and many human leukocyte cell lines. These include EBV capsid antigens: (Henle & Henle, I966; Henle, Hummeler & Henle, I966; zur Hausen et al. I967; O'Conor & Rabson, I965) , complement-fixing (CF) antigens (Armstrong, Henle & Henle, 1966; Gerber & Birch, t967; Gerber & Rosenblum, 1968) , membrane antigens (Klein et al. 1968a, b; Dunkel & Zeigel, I97O ) and early antigens. Antibodies to 'early antigens' were detected by immunottuorescence in lymphoblastoid cell lines infected with EBV (Henle et al. I97O) . Pope, Horne& Wetters (I969) found soluble CF antigens in crude preparations of Burkitt, leukaemic and infectious mononucleosis cell lines that contained EBV. The CF antibody was associated with immunofluorescent activity in all sera tested and suggested a relationship between the CF antigen and EBV. Gerber & Deal 097o) found high molecular weight soluble CF antigens in culture fluids of lymphoid cells which reacted only with EBVpositive sera. Anzai, McCombs & Benyesh-Melnick (I97O) separated CF-reactive soluble antigens from whole cell extracts of three cell lines and found that one of these may be an EBV structural protein in P3 and EB 3 Burkitt lymphoma cell lines: it was not found in an NCa7 line which apparently lacked the virus.
Preparation of a soluble fraction from cell membranes. The following cell lines were obtained from the Department of Viral Biology, Chas. Pfizer and Company, Inc., through the Special Virus Cancer Program of the National Cancer Institute: (I) Lymphoid cell line IM1, established from a young biopsy of an American patient with lymphoblastic lymphoma, with few if any observable virus particles; (z) RPMI 4265 lymphoid cell line, established from buffy coat from a patient with chronic myelogenous leukaemia, again low in particles; (3) Burkitt lymphoma cell line P3 (Jijoye) subline (3233-1o9-1) with a high content of EBV particles. These cells were washed and suspended in tris/EDTA buffer, washed several times in isotonic saline, and placed in suspension for storage at -6o °. Two fresh Burkitt tumour biopsies were obtained through the courtesy of Dr G. Klein, Karolinska Institute; (I) a submental biopsy taken one month after drug therapy from patient MM, an 8-year-old African male with recurrent tumours, and (2) a groin tumour biopsy taken ten days after drug therapy from patient RF, a Iz-year-old African female with Burkitt lymphoma, stage 2B. Normal white blood ceils were from a young American adult male, age zo. Leukaemic cells were obtained through the courtesy of Dr S. Leikin, D.C. Children's Hospital, from a I5-year-old American Negro male with acute leukaemia, in relapse. Between lO 8 and lO 9 viable cells were extracted and frozen at -6o °, the material thawed, the membranes prepared by hypotonic lysis (Hollinshead & Alford, 1969; Hollinshead et al. I97o ) and shown to be 9 ° to 98 ~o free of cell sap by assay of histocompatability antigen and electron microscopy. The membranes and cell interior extracts remaining after hypotonic lysis were sonically treated for 3 min. at below IO ° (Raytheon Model SL o2A oscillator at 9 kc./sec, and O'3A). The treated material was then centrifuged in a Spinco Model L ultracentrifuge at IOO,OOOg for I hr at 4 °. Supernatant fluids from RPMI-4265 membranes were fractionated at rooln temperature on freshly prepared Sephadex G-2oo columns (I.5 x 6o cm.) at z 3 to 25 °, pH 7"o using o.oi M-phosphate buffer. Four pooled fractions were collected in an ice bath and concentrated by Diaflo ultrafiltration (Amicon, Inc.). A standard curve of the relationship between the elution volume/void volume ratio and the molecular weight of marker proteins was established from experiments on other columns. The centre of the protein peak in fraction I was calculated to be at 57o,ooo, just ahead of standard apo-ferritin (48o,ooo); the lower limit of fraction I was at I75,ooo, just ahead of standard y-globulin (I6O,OOO). The lower limit of fraction I I was at 53,ooo and just ahead of standard ovalbumin (45,ooo). Methods for polyacrylamide gel electrophoresis were those described by co-workers (I966, 1968, 1971 ) . These methods permitted the stacking of four gels, thus increasing pore size and permitting a better resolution.
Complement-fixation tests. A fresh, reactive serum was selected from six sera obtained from patients with infectious mononucleosis. Sera were also obtained from three Caucasians with minimal to moderate lymphoma and from four patients with advanced lymphoma. Hyperimmune herpes I and herpes z guinea-pig sera were available from another study. Sera from patients with Burkitt lymphoma were obtained through the courtesy of Dr F. Rauscher and Dr R. Depue, Jun., National Cancer Institute. Burkitt lymphoma patients J316, J364, JI67, J199 and K3Io had minimal to moderate involvement, and Burkitt patients J362, K289 and J4oo had advanced involvement including invasion of the central nervous system; a description of these is given in Table I . All sera were heated at 560 for 30 rain.
Complement-fixation tests were by a macro-technique. All samples were tested for anticomplementary activity, dilutions of sera were tested against dilutions of normal cells, and controls with complement, serum, and cells were included in each test. Infectious mononucleosis sera had much lower activity than Burkitt lymphoma sera and were used at a correspondingly greater concentration. Control tests with human embryonic kidney cells and isolated normal human white blood cells, separated as above, all gave negative or trace reactions. Control tests were negative for 2, 1'5 and I units of complement, but gave 2+ reactions with o'5 units.
Tests for histocompatibility antigen (HL-A).
Cell membranes and soluble components of the cell membranes were tested individually for reactivity with broadly reactive sera using the [Cr ~1] release technique (Mann et aI. 1969) . 
RESULTS
Complement-fixation activity was detected (Table 2) in the reaction between cell membranes isolated from an American lymphoma cell line (IM1) and three Burkitt sera, whereas little fixation was detected in the reaction of these sera with cell membranes isolated from a Burkitt lymphoma cell line (P3). Preparations of cell interiors from both lymphoma cell lines showed fixation of complement in reactions with infectious mononucleosis sera and with the three Burkitt sera. It is of interest that sera from seven American lymphoma patients showed no fixation against any of these antigens; however, tests with a greater number of sera might have shown some positive results. Guinea-pig hyperimmune sera against herpes simplex virus types I and 2 were also tested and showed no reactions.
The leukaemic cell line (RPMI-4265) was tested for CF activity against a further group of four Burkitt sera (Table 2 ) and showed a similar pattern to that for the IM1 lymphoma cell line. A high molecular weight soluble membrane antigen, separated by Sephadex G-2oo gel filtration, was detected with two of four Burkitt sera (Table 2 ). Complement-fixation activity was also associated with the soluble antigens separated from leukaemic cell interior components after sonic-treatment. One of these sera (K289) was useful for detecting early antigens (Table I) . Of the two Burkitt sera which did not react with soluble membrane antigen (Table u) , one (J 167) was tested and found non-reactive to early antigen (Table I) .
To investigate the possibility that cell lines might have little antigenicity, or that antigens would be lost in preparation, we compared freshly isolated whole cells from Burkitt tumour biopsies of African patients, whole leukaemic cells, whole white blood cells from American patients of similar ages and whole cells of the leukaemic cell line (RPMI-4265) selected for further study. Two tumours were studied since most fresh biopsy specimens of Burkitt (Table 2) to cell interiors was low for both Burkitt tumour cell preparations. Similar amounts of antigen were detected on whole cells and on membranes extracted from these cells. To rule out isoantigens, whole normal white cells (buffy coat) were studied and were negative to both groups of sera, but the whole fresh white cells of the leukaemic patient reacted as the Burkitt tumours (Table 2 ). There were no antigens to react with infectious mononucleosis sera on RPMI-4265 cells. A further purification was made by disc gel electrophoresis of RPMI-4265 membrane soluble antigen in Sephadex G-zoo fraction I (Table 2 ). Duplicate separations of fraction I were made and one gel was stained for protein and the other sliced into 8 fractions and the protein eluted for testing for CF activity and for the presence of histocompatability antigens (Table 3) . CF activity was detected in proteins banding at 8.o to Io-5 cm. and almost all histocompatibility antigen activity was recovered from protein bands between 5"5 and 6'5 cm. Fractions from 4 to 8 were inactive. 
• Sephadex fraction I, see 
DISCUSSION
Our measurements of CF reactivity to the cell interiors extracts from both leukaemic and lymphoma cell lines confirm those of Pope et al. (1969) . CF reactivity in concentrated soluble components from the cell interiors of RPMI-4265 cells (Table 2 ) was detected readily, thus confirming the results of Anzai et al. (197o) who found CF-reactive soluble antigens in EBV-free as well as EBV-containing cells, including one which was EBV-specific. It is possible that tests with more concentrated immune serum might have detected smaller amounts of antigen on Burkitt cell line (P3) membranes. The P3 cells used in these studies contained greater numbers of EBV particles. Dr G. Klein (personal communication) found that HR1-K sublines of P3 cells, containing fewer virus particles, showed antigen activity in immunofluorescence tests.
One interpretation is that when virus is present in the cell, there is no genetic integration or modification of intercellular carrier states in the areas in which the membrane antigen is produced which subsequently reacts by complement-fixation with Burkitt sera. This permits a positive interpretation of the role of EBV in the production of such membrane antigens. This hypothesis can be investigated. Nucleic acid from the cell interior has been shown to cause increasing nucleolar aggregation and an outpouring of DNA into the cytoplasm. This is not so for cells already loaded with EBV. Thus, in the transformed cell carrying little or no virus, there may be an integrated nudeolar RNA which can be stimulated to cause DNA production in even greater quantity. Zur Hausen et al. (t97o) found in fresh Burkitt tumour biopsy cells, DNA-DNA hybridization which appeared to be specific for EBV-DNA, with from 2 tO 26 genome equivalents/cell.
In an admirable study, Spear et al. (I97o) found that when mammalian cells were infected with herpes simplex viruses, new glycoproteins were present in the membranes. It is not known whether these may be the same proteins as those which bind antivirus antibody and increase the density of smooth membranes (Roizman & Spear, 197 I) . It is of interest that our soluble membrane antigens were detected with the sera that measured early antigens in tests by immunofluorescence.
